DNAP.04.Another news.(PR NEWSWIRE)DNAPrint(TM) Invited to Present at the National District Attorney
Association Board of Directors Meeting
DNAPrint(TM) Invited to Present at the National District Attorneys Association B
ard of Directors Meeting
SARASOTA, Fla., March 18 /PRNewswire/ -- DNAPrint(TM) genomics, Inc.
("DNAPrint" or the "Company") has been invited to present its flagship
product, DNAWitness(TM), at the National District Attorneys Association Board
of Directors Meeting to be held March 18-20, 2004 at the Radisson Bahia Mar in
Ft. Lauderdale, Florida. The company's Technical Director of Forensics, Zach
Gaskin, will discuss how DNAWitness(TM) can aid in investigations and will
describe recent cases in which the technology has been applied. DNAWitness(TM)
is an advanced presumptive DNA test that gives an investigator a reasonably
good eyewitness at the crime scene by using the genetic code of the donor. The
test determines the Biogeographical Ancestry (BGA) of an individual giving the
percentages of East Asian, Native American, European, and Sub-Saharan African.
"Meetings such as this are helping us reach into all areas of the justice
system. Primarily, DNAWitness(TM) cases come from the crime labs, detectives
and prosecutors, so it is important to provide each of these areas with
information about the test," said Zach Gaskin, Technical Director of Forensics
with DNAPrint(TM). "Every agency in the U.S. has at least one case, if not
more, where this technology can, and should, be applied. Educating people
about DNAWitness(TM) is the first step to helping solve these crimes. Imagine
for a second if a fuzzy photo ID was left at each crime scene. That's what
this test can do for an investigation."
"Our long-term goal with this technology is to bring all crime scene
donors' DNA to the detectives. The fuzzy photos that we provide will help
investigators sort through the hundreds, sometime thousands, of bits of
information, helping them and the prosecutors determine who is and who is not
likely to be a suspect in a crime," said Richard Gabriel, the Company's CEO
and President. "DNAWitness(TM) is a flagship product that provides stunning
results that can help detectives and prosecutors by matching donor crime scene
DNA to eyewitness reports. That's just one example of its application, and
because it is a presumptive test, it can be used wherever DNA is found at a
crime scene. The test kit used to collect the evidence is free from
DNAPrint(TM) genomics and through the Lynn Peavey Company catalog. We perform
all of our analysis under the strictest confidentiality and highest quality
control and quality assurance. We are delighted and honored to be selected as
a guest speaker at the National District Attorneys Association Board of
Directors Meeting."
About DNAPrint(TM) genomics, Inc.
DNAPrint(TM) genomics, Inc. was founded by a team of scientists with
research and commercial experience in high-level mathematical modeling,
programming and molecular genetics. The DNAWitness(TM) and the
ANCESTRYbyDNA(TM) analysis is a direct result of focused research by the DNAP
research and development team.
In addition, using proprietary human genome research methods, the Company
develops pharma-predictive tests for matching patients with drugs based on
their genetic constitution, discovers disease genes for the development of new
drugs and develops new forensic genomics and consumer genomics testing
products. The Company is traded on the Nasdaq OTC Bulletin Board under the
ticker symbol: DNAP. For more information about the company, please visit
www.dnaprint.com.
For more information on our genealogical DNA-derived test,
ANCESTRYbyDNA(TM) 2.5, visit us on line at www.ancestrybydna.com helping
everyone to understand their genetic heritage.
All statements in this press release that are not historical and are
forward-looking statements within the meaning of Section 21E of the Securities
Exchange Act as amended. Such statements are subject to risks and
uncertainties that could cause actual results to differ materially from those
projected, including, but not limited to, uncertainties relating to
technologies, product development, manufacturing, market acceptance, cost and
pricing of DNAPrint's(TM) products, dependence on collaborations and partners,
regulatory approvals, competition, intellectual property of others, and patent
protection and litigation. DNAPrint(TM) genomics, Inc. expressly disclaims any
obligation or undertaking to release publicly any updates or revisions to any
forward-looking statements contained herein to reflect any change in
DNAPrint's(TM) expectations with regard thereto or any change in events,
conditions, or circumstances on which any such statements are based.
Media and Press Contacts
Richard Gabriel
DNAPrint(TM) genomics, Inc.
CEO/President
(941) 366-3400
SOURCE DNAPrint genomics, Inc.
-0- 03/18/2004
/CONTACT: Richard Gabriel, CEO - President, DNAPrint(TM) genomics,
+1-941-366-3400/
/Web site: dnaprint.com
ancestrybydna.com /
(DNAP)
CO: DNAPrint genomics, Inc.; National District Attorneys Association
ST: Florida
IN: MTC OTC
SU:
*** end of story *** |
